Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Bjorkman: Improving Potency and Breadth of Natural bNAbs |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2015-05-19 |
| Study Made Public: | 2016-07-05 |
Title
Test the breadth and potency of engineered bNAbs
Description
CAVD 495 is an immunogenicity study to test the breadth and potency of purified, engineered broadly neutralizing antibodies expressed in HEK293 cells.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.